B · Normal
[AI-assisted screening helps diabetic patients receive timely ophthalmology diagnosis and treatment] On October 19th, the London School of Hygiene and Tropical Medicine in the UK recently issued a communiqué stating that a randomized controlled trial in which the school participated found that the introduction of artificial intelligence (AI) technology in diabetic retinopathy screening can help shorten the time from screening to specialist treatment, and can help more patients who need further ophthalmology diagnosis and treatment seek medical treatment in a timely manner.
Comments